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The G-protein coupled receptor (GPCR) family is comprised of seven transmembrane
domain proteins and play important roles in nerve transmission, locomotion, proliferation
and development, sensory perception, metabolism, and neuromodulation. GPCR research
has been targeted by drug developers as a consequence of the wide variety of critical
physiological functions regulated by this protein family. Neuropeptide GPCRs are the least
characterized of the GPCR family as genetic systems to characterize their functions have
lagged behind GPCR gene discovery. Drosophila melanogaster and Caenorhabditis ele-
gans are genetic model organisms that have proved useful in characterizing neuropeptide
GPCRs.The strength of a genetic approach leads to an appreciation of the behavioral plas-
ticity that can result from subtle alterations in GPCRs or regulatory proteins in the pathways
that GPCRs control. Many of these invertebrate neuropeptides, GPCRs, and signaling path-
way components serve as models for mammalian counterparts as they have conserved
sequences and function. This review provides an overview of the methods to match neu-
ropeptides to their cognate receptor and a state of the art account of neuropeptide GPCRs
that have been characterized in D. melanogaster and C. elegans and the behaviors that
have been uncovered through genetic manipulation.
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Drosophila melanogaster
INTRODUCTION
Animals respond to environmental cues through alteration of
neural circuits that modify behavior and metabolism. The mecha-
nism underlying the regulation of the neural circuit in response to
a simple sensory cue is extremely complex and difficult to disen-
tangle in mammals. The nematode Caenorhabditis elegans offers
an excellent model organism to analyze neural circuit function. C.
elegans is 1.3 mm in length and has several desirable features. The
hermaphrodite has 959 somatic cells that form different organs
and tissues including muscle, hypodermis, intestine, reproduc-
tive organs and glands, and the nervous system. The nervous
system comprises 302 neurons whose identity and connections
have been defined by morphology and ablation studies. C. ele-
gans is also transparent such that in vivo fluorescent proteins and
dyes can be used to visualize gene expression and fat metabo-
lism in the living animal. The advantage over other systems is
that alterations within a functional neuron can be studied in
the context of the whole organism and rather than measuring
changes in fluorescence, the actual behavioral response of the ani-
mal can be monitored directly. Drosophila melanogaster is more
complex in terms of physical organization and behaviors. Some
90,000 neurons of the brain reflect a similar level of complex-
ity as the different neural cell types in humans (Venken et al.,
2011). D. melanogaster, like C. elegans, has a variety of genetic tools
that allow for forward (mutagenic screens) and reverse (targeted
gene disruption) genetics. The Drosophila UAS-Gal4 system (and
derivatives there of) enable the use of specific promoters to target
reporter genes, structural genes (for overexpression), or expression
of ds RNA for selected gene inhibition (RNAi) to specific larval or
adult tissues (Seroude, 2002). D. melanogaster and C. elegans have
recently emerged as excellent paradigms for identifying the cel-
lular mechanisms underlying human disease. Disease models are
possible if the disease can be explained in molecular terms. Both
of these non-mammalian genetic models have a strong record
of uncovering disease-related genes that have orthologs in the
human genome. These include the uncovering of genes involved in
Alzheimer’s disease (Sundaram and Greenwald, 1993; De Strooper
et al., 1999; Chakraborty et al., 2011), Parkinson’s (Feany and Ben-
der, 2000), diabetes type II (Nakae et al., 2002), polyglutamine and
other triplet repeat expansion diseases (Campesan et al., 2011),
depression (Ranganathan et al., 2001; Pandey and Nichols, 2011),
epilepsy, and schizophrenia (O’Kane, 2011).
Drosophila melanogaster and C. elegans produce and store most
classical small molecule neurotransmitters in synaptic vesicles that
cluster for release at pre-synaptic sites. These include acetylcholine,
γ-aminobutyric acid (GABA), the biogenic amines octopamine,
tyramine, dopamine, and serotonin (5-hydroxytryptamine) and
glutamate (Bargmann, 2006) function in conjunction with neu-
ropeptides that are produced as precursor proteins that are packed
with processing enzymes and stored in large dense core vesicles
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in the trans-Golgi network. Release of neuropeptide-containing
dense core vesicles is not restricted to nerve terminals and can
occur at both axons and dendrites. In C. elegans, 113 neuropeptide
genes have been identified that potentially produce 250 neu-
ropeptides. These are classified into three groups: the insulin-like
peptides (40 ins genes), the FMRFamide-related/like peptides (31
FaRP or flp genes), and the neuropeptide-like peptides (42 nlp
genes; Nathoo et al., 2001). Two recent reviews summarize the
synthesis, processing, and function of C. elegans neuropeptides
(Husson et al., 2007; Li and Kim, 2008). In D. melanogaster, 119
neuropeptide genes have been predicted with 46 neuropeptide
families characterized biochemically from 19 precursors (Clynen
et al., 2010). In C. elegans, there are over 1100 G-protein cou-
pled receptors (GPCRs) with approximately 100 thought to be
specific for neuropeptides (Bargmann, 1998). D. melanogaster
has approximately 160 GPCRs (far less than C. elegans with 44
exhibiting characteristics consistent with peptide ligand receptors
(Hewes and Taghert, 2001). In both organisms, very few GPCRs
have been matched with their respective neuropeptides and much
less is known as to how each neuropeptide GPCR functions in
neurotransmission or behavior. GPCRs can be separated struc-
turally into several classes or subfamilies. The largest of these
are the rhodopsin-like which are activated by small ligands and
peptides. The secretin class of GPCRs have large extracellular
domains that selectively bind glycoproteins. The metabotropic
glutamate/pheromone GPCRs have domains that share sequence
similarity with periplasmic binding proteins of bacteria involved in
the transport of ions, amino acids, sugars, and peptides. The adhe-
sion and frizzled class of GPCRs also have unique N-terminal bind-
ing domains with unique binding properties (Fredriksson et al.,
2003; Krishnan et al., 2012). Given the diversity of GPCR types
and varied functions this review focuses on some of the genetic
and molecular techniques that have been used to specifically de-
orphan neuropeptide GPCRs in C. elegans and D. melanogaster
and decipher their role in regulating behavior and physiology.
MATCHING NEUROPEPTIDES TO ORPHAN RECEPTORS
METHODOLOGY
Only a limited number of reverse pharmacological approaches
have been applied to match a peptide ligand to its receptor (i.e., de-
orphanization) in D. melanogaster and C. elegans. All approaches
are based on expression of the GPCR in a membrane system that
will complete a signaling pathway that can be assayed. One of
the more common assays used to de-orphan GPCRs is the GTPγS
assay (Larsen et al., 2001). The GTPγS assay is one of the most sen-
sitive assays for screening GPCRs and is widely used to characterize
full and partial agonists and antagonists. In this assay, the GPCR of
interest is expressed in mammalian cells such as Chinese hamster
ovary (CHO) or human embryonic kidney (HEK293) cells. The
plasma membrane replete with the recombinant GPCR of interest
is purified and incubated with GDP and a potential neuropeptide
ligand. A radiolabeled non-hydrolyzable GTP analog [35S] GTPγS,
is then added. The premise of the assay is that if the neuropep-
tide has activated the receptor, the G-protein α-subunit exchanges
GDP for GTP or in this case [35S]GTPγS which accumulates in the
membrane and is easily measured. A second type of assay monitors
cAMP levels. In this case, a receptor expressed in mammalian cells
can be activated by adding a neuropeptide to the culture media.
Upon activation, if exchange of GDP to GTP occurs using a Gαs
subunit, adenylate cyclase activity will be stimulated, converting
ATP to cAMP. Conversely, if the GDP to GTP exchange occurs
using a Gαi subunit, adenylate cyclase is inhibited, and cAMP levels
decline. In practice, a reporter construct that provides a promoter
with multiple cAMP response elements controlling expression of
the gene luciferase is co-transfected into cells with the receptor.
Enhanced expression of luciferase occurs when cAMP increases.
Luciferase catalyzes the oxidation of the firefly specific substrate,
d-luciferin, to produce light which can be directly measured. If sig-
naling occurs through Gαi, which depresses cAMP levels, cells can
be treated with forskolin (which activates adenylate cyclase) prior
to neuropeptide application. In this case, cAMP levels can be mea-
sured in cell extracts by incubation with a biotinylated-anti-cAMP
antibody and a anti-cAMP antibody coupled to an acceptor bead.
Streptavidin-coupled to a donor bead is then added to complex
with biotin. Excitation of the donor bead with a laser (680 nm)
produces singlet oxygen which can travel up to 200 nm and excite
the cAMP – antibody bound acceptor bead in the complex. The
acceptor bead then emits light which can be directly measured.
Intracellular Ca2+ can also be used as a measure of GPCRs that
couple through Gq. Gq activates phospholipase Cβ which gener-
ates inositol triphosphate and diacylglycerol. Inositol triphosphate
activates release of intracellular Ca2+ stores from the endoplasmic
reticulum. Ca2+ can be measured by Ca2+ sensitive indicators such
as Fluo-4. Alternatively, cells can be co-transfected with a gene
that expresses apoaequorin. In the presence of the cofactor coe-
lenterazine, a complex is formed that generates light proportional
to the quantity of Ca2+. The relative simplicity of these assays
has resulted in their widespread use in matching neuropeptides
to their GPCRs, although the expression of C. elegans GPCRs in
mammalian cells has encountered a number of pitfalls. For exam-
ple, stable cell lines expressing some GPCRs cannot be generated
because of toxicity problems. In addition, some GPCRs appear to
be active only if cultured cells are incubated at 28˚C rather than
the normal 37˚C (Harada et al., 1987; Geary et al., 1999; Kubiak
et al., 2003a,b).
Drosophila melanogaster GPCRs have also been de-orphaned
using a β-arrestin2-green fluorescent protein (GFP) transloca-
tion assay (Johnson et al., 2003). In this assay, following ligand-
GPCR interaction in mammalian cells, β-arrestin2-GFP translo-
cates from the cytoplasm to the cell membrane or receptor-bearing
endosomes as part of termination of signaling (Barak et al., 1997).
G-protein coupled receptors of both C. elegans and D.
melanogaster have also been expressed in Xenopus laevis oocytes
along with a G-protein-gated inward rectifying potassium chan-
nel (GIRK; Harada et al., 1987). Gating results from release of
the Gβγ subunits, which, upon receptor activation, then inter-
act with GIRK. Measurement is through whole cell voltage-clamp
recordings.
Caenorhabditis elegans GPCRs have been expressed in the phar-
ynx of C. elegans by creating a transgenic animal with a GPCR
construct that is under the control of a heat shock promoter.
Action potentials are measured by placing a microelectrode into
an exposed terminal pharyngeal bulb. For C. elegans neuropeptide
receptor-1 (NPR-1), this method gave slightly different results than
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the Xenopus assay when the receptor was tested with several pep-
tides (see below). Human somatostatin receptor and chemokine
receptor 5 (CCR5) have been expressed in C. elegans nocicep-
tive neurons ASH and ADL by transformation of the genes under
the control of the gpa-11 promoter. Transgenic animals showed
an avoidance response to the cognate peptide placed between the
worms and an attractant (Teng et al., 2006). This study has been
extended to show that animals expressing CCR5 in nociceptive
neurons will avoid Escherichia coli that expressed the natural lig-
and MIP-1α (Teng et al., 2008). As a cautionary note, this approach
may only be applicable to non-modified peptides such as MIP-1α
because E. coli does not have the enzymes necessary for some mod-
ifications, such as C-terminal amidation that some neuropeptides
require for activity.
Despite the techniques outlined above, only a very small num-
ber of C. elegans and D. melanogaster receptors have been matched
to their cognate ligand. At present, most families of known neu-
ropeptides have been matched to receptors in D. melanogaster
(Hewes and Taghert, 2001; Johnson et al., 2003; Clynen et al.,
2010). The de-orphaning of C. elegans neuropeptide receptors has
not been as rapid as in D. melanogaster. However, some of the
C. elegans receptors that have been studied have provided bet-
ter insights into components of the signal transduction pathways.
Both model organisms though have advantages in that trans-
genic animals can be generated that overproduce neuropeptides
or GPCRs and the availability of mutants that give rise to spe-
cific phenotypes that result from the suppression of neuropeptide
and/or GPCR-linked functions.
COMPARING FUNCTION OF STRUCTURALLY CONSERVED
PEPTIDES AND RECEPTORS IDENTIFIED IN DROSOPHILA
AND CAENORHABDITIS
Insect systems have proven invaluable in revealing primary peptide
structures that define many neuropeptide families and for develop-
ing in vitro physiological assays that provide clues to in vivo func-
tions. The signal transduction pathways for most neuropeptides
though are only vaguely understood beyond their interaction with
their cognate receptor. Genetic systems such as D. melanogaster
and C. elegans are now extending our understanding of the steps
between neuropeptide release to final physiological action. Many
of these peptide-GPCR interactions lead to conserved functions.
For example, allatostatin-like peptides appear to influence forag-
ing behavior in D. melanogaster and C. elegans. These systems have
also been instrumental in uncovering additional neuropeptide and
neuropeptide GPCR functions.
NEUROPEPTIDE F, NPY/NPF PEPTIDES, AND RECEPTORS
In vertebrates, a 36 amino acid neuropeptide Y (NPY) functions
as a neuromodulator to stimulate feeding behavior (Clark et al.,
1984; Kalra, 1997). Roles of vertebrate NPY include suppression of
responsiveness to adverse stimuli and in promotion of food search
and acquisition under adverse conditions (Thorsell and Heilig,
2002). Destruction of NPY-expressing neurons in mice results
in starvation of the animals (Pedrazzini, 2004). NPY is thought
to work through a specific NPY receptor, to repress the activity
of inhibitory neural circuits that then promotes feeding behavior
(Klapstein and Colmers, 1993; Browning and Travagli, 2003).
In invertebrates, neuropeptide F is an ortholog of vertebrate
NPY but differs in a C-terminal phenylalanine rather than tyrosine
(Brown et al., 1999). Drosophila NPF (DromeNPF) is expressed in
the brain and midgut of larvae and adults (Brown et al., 1999).
A single receptor, Drome NPF receptor (DromeNPFR) has been
identified through expression of the receptor in mammalian cells
and binding assays (Garczynski et al., 2002; Table 1). In common
with vertebrate NPY, DromeNPF, and its receptor have been asso-
ciated with the control of social and feeding behaviors. DromeNPF
levels are high in larvae, when they remain attracted to food,
then fall to lower levels in subsequent developmental stages in
which feeding is reduced. Overexpression of the DromeNPFR at
later developmental stages encourages feeding behaviors that differ
from wild type, whereas underexpression of DromeNPFR leads to
a food aversion response in earlier larvae that would normally feed
(Wu et al., 2003). Food-associated memory is promoted by starva-
tion and inhibited by satiety in Drosophila. Stimulation of neurons
that express DromeNPF mimics food deprivation and promotes
memory performance in satiated flies. This memory performance
requires the expression of the DromeNPFR in six dopaminergic
neurons whereas blocking these neurons releases memory per-
formance in satiated flies and suppresses memory performance
in hungry flies. This suggests that dopamine and DromeNPF act
together to coordinate memory performance, based on nutritional
status (Krashes et al., 2009). DromeNPF also functions in fly-
aversive responses to a variety of stressors. NPF appears to act
antagonistically to insulin signaling systems in regulating aversive
responses (Wu et al., 2005). In aversion responses, DromeNPF
suppresses PAIN neurons through attenuation of transient recep-
tor potential (TRP) channel-induced neuronal excitation (Xu
et al., 2010). iDromeNPF signaling has been implicated in a
wide range of behaviors and has recently been shown to have a
modulatory effect on fly aggression. Drug-induced increases of 5-
hydroxytryptamine (serotonin) amplify aggression amongst flies,
whereas silencing of the serotonergic circuits leads to a lack of
response following application of exogenous serotonin; however,
the aggression response still exists. Silencing of the DromeNPF
circuit leads to an increase in fly aggression, showing that sero-
tonin and DromeNPF signaling systems act together to regulate fly
aggression (Dierick and Greenspan, 2007). The DromeNPF signal-
ing pathways also modulate acute ethanol sensitivity (Wen et al.,
2005) and appear to have a male-specific function in courtship
behavior. DromeNPF also has a possible role in circadian rhythms
(Lee et al., 2006) and is potentially involved in the control of
evening activity (Hermann et al., 2012). The signaling pathways
regulating these later phenotypes are still poorly understood.
The C. elegans GPCR (C39E.6.6=Caeel npr-1) shares homol-
ogy with the vertebrate NPY receptor family. Caeel npr-1 is
expressed in at least 20 neurons. Two natural alleles of NPR-1 that
differ by a single amino acid at position 215, which likely affects
G-protein signaling show two behavioral phenotypes termed“soli-
tary”versus“social.”Animals, typified by the N2 Bristol strain used
in most labs as a wild type strain, express Caeel npr-1 with valine
at position 215 (Caeel npr-1 215V). This Caeel npr-1 allele results
in animals with reduced locomotory activity on a bacterial lawn
and they disperse over the lawn as solitary individuals. Animals
such as the Hawaiian isolate CB4856, express Caeel npr-1 with
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Table 1 | Receptor-ligand interaction affinities as measured in heterologous expression systems.
Receptor gene Peptide ligand Peptide sequence EC50 Reference
C. elegans
Caeel C39E6.6 (NPR-1) FLP-21 GLGPRPLRFa 215V 2.2–77 nM, 215F 59–370 nM Kubiak et al. (2003b)
** FLP-21 GLGPRPLRFa 215V −108, 215F −104 Rogers et al. (2003)
** FLP-18-1 DFDGAMPGVLRFa 215V −9.3, 215F 0
** FLP-18-2 EMPGVLRFa 215V −32, 215F 0
** FLP-18-3 SVPGVLRFa 215V −9.7, 215F 0
** FLP-18-4 EIPGVLRFa 215V −8, 215F 0
** FLP-18-5 SEVPGVLRFa 215V −6.8, 215F 0
** FLP-18-6 DVPGVLRFa 215V −9.7, 215F 0
Caeel npr-2 T05A1.1 Unknown
Caeel npr-3 C10C6.2 FLP-15-1 GGPQGPLRFa 162.4 nM Kubiak et al. (2003a)
FLP-15-2 RGPSGPLRFa 250.6 nM
Caeel Y58G8A.4 (npr-5)
Splice variants a and b
FLP-18-6 DVPGVLRFa a: 32.3 nM; b: 45.9 nM Rogers et al. (2003)
FLP-18-3 (K) SVPGVLRFa a: 28.3 nM, b: 48.3 nM
FLP-18-3
Truncated
SVPGVLRFa a: 14.4 nM, b: 43.3 nM
FLP-18-5 SEVPGVLRFa a: 25.9 nM, b: 58.4 nM
FLP-18-4 EIPGVLRFa a:117.2 nM, b: 124 nM
Caeel C26F1.6 FLP-7-2 TPMQRSSMVRFa 1.02±0.24µM Mertens et al. (2005b)
FLP-7 Truncated SMVRFa 0.096±0.016µM
FLP-11-1 AMRNALVRFa 1.34±0.41µM
FLP-7-1 SPMQRSSMVRFa Inactive
FLP-7-3 SPMDRKMVRFa Inactive
FLP-7-4 SPMERSAMVRFa Inactive
Caeel Y59H11AL.1 FLP-7-3 SPMERSAMVRFa <0.7 [28˚C]–1.1 [37˚C]µM Mertens et al. (2006)
FLP-7-2 TPMQRSSMVRFa 2.5µM
FLP-7-1 SPMQRSSMVRFa 5.0µM
FLP-7-4 SPMDRSKMVRFa 5.0µM
FLP-1-8 KPNFMRYa 0.1µM
FLP-9 KPSFVRFa 5.0µM
FLP-11-1 AMRNALVRFa 0.75µM
FLP-11-2 ASGGMRNALVRFa 2.5µM
FLP-11-3 NGAPQPFVRFa 1.0µM
Caeel T19F4.1 FLP-2-1 SPREPIRFa 53.1±7.7 nM Mertens et al. (2005a)
FLP-2-2 LRGEPIRFa2 54.4±6.2 nM
Caeel C46F4.1 (egl-6) FLP-10 QPKARSGYIRFa 11 nM Ringstad and Horvitz
(2008)FLP-17-1 KSAFVRFa 28 nM
FLP-17-2 KSQYIRFa 1 nM
Caeel C13B9.4 (pdfr-1) PDF-1a SNAELINGLIGMDLGKLSAVa 127.4 nM Janssen et al. (2008b)
PDF-1b SNAELINGLLSMNLNKLSGAa 360 nM
PDF-2 NLP-37 NNAEVVNHILKNFGALDRLGDVa 33.8 nM
Caeel;Y39A3B.5 (ckr-2) NLP-12A DYRPLQFa 56.7 nM Janssen et al. (2008a)
NLP-12B DGYRPLQFa 14.7 nM
D. melanogaster
Drome NPFR CG1147 DromeNPF
CG10342
SNSRPPRKNDVNTMADAYKFL
QDLDTYYGDRARVRFa
65 nM* Garczynski et al.
(2002)
Drome sNPFR=
NPRF76F CG7395
Drome sNPF
CG13968
AQRSPSLRLRFa 5.1×10−8 Mertens et al. (2002)
SPSLRLRFa 4.2×10−8
PQRLRWa 3.1×10−8
PMRLRWa 7.5×10−8
(Continued)
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Table 1 | Continued
Receptor gene Peptide ligand Peptide sequence EC50 Reference
DromeFR CG2114 Drome FMRF-1 DPKQDFMRFa 2.0 nM Meeusen et al.
(2002)Drome FMRF-2 TPAEDFMRFa 2.8 nM
Drome FMRF-3 SDNFMRFa 1.9 nM
Drome FMRF-4 SPKQDFMRFa 2.5 nM
Drome FMRF-5 PDNFMRFa 1.8 nM
N. bullata APPQPSDNFIRFa 3.5 nM
N. bullata pQPSQDFMRFa 2.0 nM
Drome CG13229 Unknown
Drome PDFR CG1758 Drome PDF
CG6492
NSELINSLLSLPKNMNDAa 25 nM Mertens et al.
(2005c)
Drome DH31 TVDFGLARGYSGTQEAKHRMG
LAAANFAGGPa
218.6 nM
Drome CCKLR Drome DSK FDDY(SO(3)H)GHLRFa 5.3 nM Kubiak et al. (2002)
*Determined through a competition assay which displaced radioactive peptide from the receptor.
**Values represent alteration of current in response to neuropeptide application in the Xenopus assay.
phenylalanine at position 215 (Caeel npr-1 215F). Caeel npr-1 215F
animals display a “bordering” phenotype as they move rapidly on
bacterial food to areas where the food is thickest, and burrow.
These animals also show social behavior by interacting with each
other to form clumps that can contain hundreds of animals (de
Bono and Bargmann, 1998). Caeel NPR-1 acts as an inhibitor of
social behavior as Caeel npr-1 loss-of-function (lf) mutants dis-
play social behavior. This results in part from Caeel npr-1 (lf)
exhibiting enhanced attraction to low levels of the ascaroside
pheromone (Macosko et al., 2009). The Caeel npr-1 215 Valine
(V) allele is dominant to the Caeel npr-1 215 Phenylalanine (F)
allele so that heterozygotes will display solitary behavior. Genetics
and targeted expression studies have suggested that NPR-1 acts
through neurons AQR, PQR, and URX that are exposed to body
fluids (Coates and de Bono, 2002) to suppress aggregation and
bordering by inhibiting the expression/activity of two α/β soluble
guanylate cyclases GCY-35 and GCY-36 that are required to acti-
vate a cGMP-gated ion channel (TAX-2/TAX-4) encoded by the
tax-2 and tax-4 genes (Cheung et al., 2004; Gray et al., 2005). Social
animals may display aggregation and bordering activity as a means
of avoiding high O2 levels (hyperoxia) on food. In solitary Caeel
NPR-1 215V animals, food suppresses avoidance of hyperoxia by
signaling through Caeel NPR-1 via GCY-35/GCY-36 and the TGF-
β homolog DAF-7 (Cheung et al., 2005; Chang et al., 2006). On
food, Caeel NPR-1 215V also promotes avoidance of high levels of
CO2 whereas the Caeel NPR-1 215F-bearing animal only exhibits
a weak avoidance to CO2. Indeed, an increase in CO2 leads to
a burst of turning in wild type (N2) worms; however, the Caeel
npr-1 215F strain does not respond. Up or downshifting of O2
has a dramatic effect on turning in Caeel npr-1 215F. The activity
of Caeel NPR-1 may thus serve to integrate inputs from O2- and
CO2-sensing pathways and generate an appropriate response with
respect to availability of food (Bretscher et al., 2008; Chang and
Bargmann, 2008; Hallem and Sternberg, 2008). The O2 and CO2-
sensing pathways may control which peptides become involved
in regulating Caeel NPR-1. A globin-like gene (glb-5) appears to
cooperate with Caeel npr-1 to mediate responses to O2 and CO2
concentrations. Expression of the globin-like gene (glb-5) in ani-
mals with a lf allele of Caeel npr-1 showed suppressed aggregation
behavior (McGrath et al., 2009).
Caeel NPR-1 has recently been shown to play a role in innate
immunity, with Caeel npr-1(lf) animals showing an increased sus-
ceptibility to infection by the bacteria Pseudomonas aeruginosa.
A similar initial signaling pathway may be used since one of the
soluble guanylate cyclases (GCY-35) expressed in AQR, PQR, and
URX neurons, and the cGMP-gated ion channel TAX-2/TAX-4
are required (Styer et al., 2008). Caeel npr-1 has been implicated
in hyperoxia avoidance in the presence of an exopolysaccharide
matrix characteristic of mucoid bacteria. OSM-9 is part of the
TRP Vanilloid (TRPV)-like ion channel that is within the ASH and
ADL nociceptive neurons (Kapfhamer et al., 2008). The TRPV-like
channel mutant (osm-9) mutant exhibited mucoid bacterial avoid-
ance as a consequence of the lack of induction of the Caeel NPR-1
pathway. Worms that lack the TRPV-like channel and guanylate
cyclase (gcy-35) showed restored Caeel NPR-1-dependent oxygen
sensitivity and absence of pathogen avoidance exhibited by TRPV
(osm-9) mutant (Reddy et al., 2011).
The TRPV-like channel appears to work with Caeel NPR-
1 in several instances of behavioral adaptation/acute tolerance.
For example, following exposure of wild type C. elegans to
ethanol, intoxication can occur which is assayed by hyperexci-
tation followed by inhibition of locomotor activity and egg laying.
Decreased intoxication as a result of acute tolerance is observed
in Caeel NPR-1 215F animals which show a dramatic recov-
ery to ethanol exposure relative to Caeel NPR-1 215V animals.
Ethanol-induced clumping of animals was suppressed by the loss
of the cGMP-gated ion channel (tax-4) and the TRPV-like chan-
nel (osm-9 ; de Bono et al., 2002). Caeel npr-1 expression in RMG
interneurons acts synergistically with TRPV-like channel (osm-9)
in parallel pathways to regulate aversive behaviors at high temper-
ature with npr-1(lf) animals show an increased threshold for heat
avoidance (Glauser et al., 2011).
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The initial study to de-orphan Caeel NPR-1 used expression of
Caeel npr-1 in a mammalian (CHO) cell line screened with 200
synthetic invertebrate peptide sequences. A single Ascaris suum
neuropeptide AF9 (Cowden and Stretton, 1995) was identified as
an activating ligand. AF9 is a FMRFamide-related peptide (FaRP)
unrelated in sequence to NPY. This peptide sequence has been
found in the C. elegans genome and is known as FMRFamide-
like peptide-21 (FLP-21; Kubiak et al., 2003b). FLP-21 activation
of Caeel NPR-1 results in inhibitory signaling through Gi/Go
proteins and inhibition of cAMP production. In GTPγS binding
assays, FLP-21 displayed higher activity with Caeel NPR-1 215V in
comparison to Caeel NPR-1 215F (Kubiak et al., 2003b; Table 1).
Higher FLP-21 activation of Caeel NPR-1 215V was also noted
when the receptor was expressed in Xenopus oocytes and assayed
for GIRK channel activation (Rogers et al., 2003; Table 1). This is
consistent with the observation that social behavior is repressed
in Caeel NPR-1 215V. In the Xenopus assay, in addition to FLP-21,
six unique FaRPs encoded by flp-18 were found to activate Caeel
NPR-1 215 V but not Caeel NPR-1 215F (Table 1). Using a differ-
ent assay system in which Caeel NPR-1 isoforms were expressed
in the C. elegans pharynx, both isoforms were activated by the sole
FLP-21 peptide and all FLP-18 peptides and signaling may occur
through Gαq (Rogers et al., 2003). The expression patterns of flp-
18 and flp-21 have limited overlap. flp-18 is expressed in neurons
AVA, AIY, and RIG, motor neurons RIM and pharyngeal neurons
M2 and M3. flp-21 is expressed in sensory neurons ADL, ASE, and
ASH, motor neuron MRA and pharyngeal neurons MC. M2 and
M4. Deletion of flp-21 has a limited effect on increasing aggrega-
tion and bordering in Caeel npr-1 215V animals but does enhance
aggregation in Caeel npr-1 215F animals (Rogers et al., 2003). This
supports a role for FLP-18 peptides acting in conjunction with
FLP-21 to regulate behavior. However, this is not always the case as
FLP-21 does not appear to act in acute ethanol tolerance, suggest-
ing that FLP-18 may be the active ligand. FLP-21 may act solely
with Caeel NPR-1 in adaptation to heat avoidance (Glauser et al.,
2011).
C53C7.1 is another C. elegans receptor related to the Drosophila
neuropeptide F-like receptor. Two isoforms of C53C7.1 are gen-
erated by alternative splicing. A single patent report identifies a
different FMRFamide-like peptide encoded by the flp-3 gene as
the ligand for C53C7 (Lowery et al., 2003).
SHORT NPF AND sNPF RECEPTORS
The D. melanogaster gene for short NPF (sNPF) encodes a pre-
cursor polypeptide that, upon processing, would release two C-
terminal RLRFamides (sNPF-1, sNPF-2) and two RLRWamides
(sNPF3, sNPF4; Hewes and Taghert, 2001; Vanden Broeck, 2001).
Several thousand neurons in the CNS of D. melanogaster express
sNPFs suggesting an array of potential functions for these neu-
ropeptides (Nassel et al., 2008). A single neuropeptide GPCR
(NPRF76F, CG7395, sNPRF1) is activated by all four sNPFs
(Mertens et al., 2002; Table 1). Many sNPF-expressing neurons
also co-express classic neurotransmitters suggesting that sNPF
could act as a co-transmitter or neuromodulator (Nassel et al.,
2008). sNPFs are also produced in the hypocerebral ganglion and
in the anterior and middle midgut of D. melanogaster although
the function of sNPF at these sites is unknown (Veenstra et al.,
2008). In D. melanogaster, sNPF and sNPFR1 regulate body growth
and metabolism by activating extracellular signal-related kinases
(ERK) that mediate insulin-like peptide signaling (Lee et al.,
2004). This response appears to show evolutionary conservation
as mammalian NPY also mediates growth, metabolism, and lifes-
pan through ERK-mediated insulin signaling. Olfactory receptor
neurons also express sNPF (Carlsson et al., 2010) and this expres-
sion is responsible for starvation-dependent enhancement of food
searching behavior. Starvation results in an insulin signal that
functions via the phosphoinositide 3-kinase pathway to upregu-
late sNPFR1 expression in odorant receptor neurons which in turn
sensitizes select sensory neurons to promote food search behavior
(Root et al., 2011).
In C. elegans, the sequence of NPR-2 (T05A1.1) shares 26%
amino acid sequence identity with the D. melanogaster sNPFR1.
Three isoforms of NPR-2, one of 430 aa and two of 387 aa that
differ at their amino-terminus, could potentially be generated by
alternative splicing. RNAi experiments have demonstrated that
knockdown of NPR-2 expression leads to a reduction in loco-
motion (Keating et al., 2003). Reduction in NPR-2 expression is
also associated with an increase in accumulation of intestinal lipid
(Cohen et al., 2009). The endogenous ligand is unknown. FLP-
18 and FLP-21 were tested in the Xenopus oocyte assay and were
unable to activate NPR-2 (Cohen et al., 2009).
Caenorhabditis elegans npr-3 (C10C6.2) is currently thought to
specify only one GPCR of 376 aa that is expressed in the nerve
cord and in excitatory and inhibitory motorneurons in the region
of the nerve cord. The NPR-3 sequence, like NPR-2 is most related
to the D. melanogaster sNPFR1 sharing 30% amino acid sequence
identity. In C. elegans, the functions of this GPCR are still being
established. In one RNAi screen, a knockdown of NPR-3 led to
abnormal locomotion, with animals exhibiting sluggish behavior
and a flat locomotory path as body bends were reduced (Keating
et al., 2003). A second RNAi screen found that reduction of NPR-3
in a lin-35 background (loss of lin-35 results in enhanced RNAi)
led to reduced brood size and protruding vulvas (Ceron et al.,
2007). Neuropeptides specified by flp-15 appeared to be the only
peptides that could activate NPR-3 in a GTPγS assay with mem-
branes prepared from npr-3 transiently transfected CHO cells. In
this assay, FLP-15-2 was a more potent activator than FLP-15-1
(Table 1). This interaction appears to be specific since a pep-
tide such as FLP-21 (Table 1), which shares the carboxyl-terminal
GPLRFamide, was inactive. NPR-3 appears to require a distinct
conformation as activity was only observed when transiently NPR-
3 transfected cells were incubated at 28˚C. Membranes prepared
from cells incubated at 37˚C were inactive. Attempts to make a
stably transformed NPR-3 cell line with CHO, HEK293, or COS7
cells were unsuccessful and resulted in cell death. In a transient
expression assay; NPR-3 appears to activate via pertussis toxin-
sensitive Gi/Go coupled signaling pathways which suggests that
NPR-3 action is inhibitory (Kubiak et al., 2003a).
A second potential sNPF-like GPCR in C. elegans is Y58G8A.4
(NPR-5). NPR-5 RNA is spliced to generate two receptor isoforms
of 397 aa (NPR-5a) and 433 aa (NPR-5b) that differ in sequence
at the carboxyl-terminus. NPR-5 is most similar (31% amino acid
sequence identity) to the D. melanogaster receptor CG7395 that
encodes a NPF-like GPCR; that binds sNPF (Mertens et al., 2002).
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Both isoforms of NPR-5 were assayed for activation with 150 syn-
thetic peptides in a transient expression system in CHO cells. The
most potent activators in a Ca2+ mobilization assay were peptides
derived from the flp-18 gene. FLP-18 peptides showed activation
with EC50 values in the nM range, with most having similar poten-
cies using either NPR-5a or b (Table 1). The least active peptide
was the longest FLP-18-1 which is also the least active when assayed
with the NPF-like receptor NPR-1 (Rogers et al., 2003). FLP-18-1
has been isolated as a processed peptide with the first three amino-
terminal amino acids removed which may result in a more potent
form of the peptide (Clynen et al., 2009). The sole FLP-21 peptide,
that is the cognate ligand for NPR-1, was found to activate both
forms of NPR-5 but with far less potency (Kubiak et al., 2008).
This is not surprising since FLP-18 peptides have been shown to
activate NPR-1 in oocyte expression assays as well as in a C. ele-
gans pharyngeal expression assay (Rogers et al., 2003). It is unclear
whether the FLP-18 and FLP-21 peptides work together. The two
isoforms of NPR-5 may activate multiple signal transduction path-
ways as contributions from Gq, Gs, and Gi were observed (Kubiak
et al., 2008). Deletion mutants of flp-18 display no measurable
phenotype.
FMRFAMIDES AND FMRFAMIDE-RELATED RECEPTORS
In vertebrate systems, neuropeptides with C-terminal sequence
FMRFamide and FaRPs function in regulation of muscle contrac-
tion, feeding behavior, and learning and memory (Panula et al.,
1996).
In D. melanogaster, FMRFamides are expressed from a single
gene that encodes a precursor specifying 8 FMRFamide peptides.
Five copies of the peptide Drome FMRF-1 would be released from
the precursor (Table 1; Schneider et al., 1993). In vitro assays have
established that FMRFamides function as modulators of muscle
contraction, including in larval heart muscle; crop, foregut, and
muscle of the body wall (Nichols et al., 2002; Nichols, 2003).
The D. melanogaster FMRFamide GPCR (CG2114; Drome FR)
is expressed in most larval and adult tissues. Drome FR was
de-orphaned in two independent studies. In an aequorin biolu-
minescence assay, Drome FMRFamides 1–5 (numbered as unique
FMRFamide-terminating peptide sequences from amino to the
carboxyl-terminus of the precursor) were found to elicit a cal-
cium response in a dose-dependent manner in CHO expressing
(Table 1). Neobellieria bullata FMRFamide peptides were found
to be active with the Drome FR with comparable potencies
to native Drome FMRFamides (Table 1; Meeusen et al., 2002).
Drome FMRFamide-5 was the most potent ligand in both studies
(Cazzamali and Grimmelikhuijzen, 2002; Meeusen et al., 2002).
Both studies found that the Drome FR can be activated by non-
FMRFamide peptides such as Drome sNPF-1 and Drome myosup-
pressin; however, these peptides require much higher concentra-
tions to elicit a response. Despite the high concentration required,
FMRFamides were recently shown to act post-synaptically, induc-
ing slow larval body wall contractions and increased tonus of
the body wall muscles. The latter action of Drome FMRFamide
requires activation of Drome FR and the Drome myosuppressin
GPCR as well as an influx of calcium through L-type calcium
channels (Klose et al., 2010). A role in reproduction had been
suggested for Drome FR (Meeusen et al., 2002) as it is related in
sequence to a sex peptide receptor (CG16752); however, the Drome
FR could not replace the sex peptide receptor in in vitro expression
assays (Yapici et al., 2008). Drome CG2114 shares 16–20% amino
acid identity with C. elegans GPCRs F21C10.9 and C26F1.6. Fol-
lowing knockdown of the expression of the C. elegans receptor
C26F1.6 by RNAi, a hyperactive egg laying phenotype is observed
suggesting that this GPCR functions in control of egg produc-
tion (Keating et al., 2003). Using expression of Caeel C26F1.6
in mammalian cells, only two neuropeptide sequences elicited a
dose-dependent response Peptide FLP-7-2 which is found as two
copies within the flp-7 gene-encoded precursor was the most active
followed by FLP-11-1 which is one of four peptides specified by
the flp-11 gene. Related peptides FLP-7-1, FLP-7-3, and FLP-7-4
processed from the FLP-7 precursor were inactive (Mertens et al.,
2004, 2005b; Table 1). The FLP-7-2 peptide is likely cleaved at
the arginine at the fifth position from the amino-terminus, as
truncating the peptide to the terminal 5 amino acids was more
active in receptor activation than the predicted full-length peptide
(Mertens et al., 2005b). If processing does occur, all peptides from
the FLP-7 precursor could be active peptides for receptor Caeel
C26F1.6. Alternatively, the unique amino-terminal sequences may
be required for targeting.
Caeel Y59H11AL.1 is a FaRP receptor that is related to the inver-
tebrate tachykinin/mammalian neurokinin family of receptors.
Caeel Y59H11AL.1 is most closely related to the Drosophila NPY-
like receptor (CG5811, DromeNepYr) which is a tachykinin family
member. Drome NepYr has not been assigned a functional role.
However, the Caeel Y59H11AL.1 receptor appears to play a role
in growth and reproduction as knockdown of Caeel Y59H11AL.1
gene expression results in small animals with a reduced brood size
(Ceron et al., 2007). Expression of the Caeel Y59H11AL.1 gene
results in two potential RNA splice variants that lead to two recep-
tors of 427 aa and 434 aa. The two receptors differ by alteration of
peptide sequence at the carboxyl-terminal region of the receptor.
Of 68 neuropeptides tested against Caeel Y59H11AL.1 expressed
in mammalian cells, the Caeel flp-7 gene-encoded peptide FLP-
7-3 was the most potent peptide (Table 1; Mertens et al., 2006).
Three other peptides processed from the Caeel FLP-7 precursor,
FLP-7-1, FLP-7-2, and FLP-7-4 were less active. Peptide FLP-7-4
appears to be the only Caeel FLP-7 precursor-derived peptide that
uniquely activates Caeel Y59H11AL.1, as the others activate Caeel
C26F1.6 as well. This result is surprising since the two receptors
share limited sequence identity. Other peptides that showed weak
activation of Caeel Y59H11AL.1 were Caeel FLP-1-8, FLP-9, and
FLP-11-1-3 (Table 1; Mertens et al., 2006). Activation by multi-
ple related peptides suggests a functional redundancy in peptide
binding or possibly a less selective requirement of the receptor to
respond to a variety of signals.
Another FaRP receptor in C. elegans is T19F4.1. RNA splice
variants give rise to two receptors of 402 aa (Caeel T19F4.1a) and
432 aa (Caeel T19F4.1b). The difference between the receptors
resides with the intracellular carboxy-terminus. After transient
expression of each receptor in mammalian cells, two peptides,
FLP-2-1 and FLP-2-2 derived from the Caeel flp-2 gene precur-
sor were found to activate in a dose-dependent manner either
Caeel T19F4.1a or Caeel T19F4.1b (Table 1). A stable transformed
mammalian cell line expressing Caeel T19F4.1b showed far less
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activation with FLP-2-1 and was less responsive when challenged
with FLP-2-2 (Mertens et al., 2005a). The reasons for this are
unclear. In a genome-wide RNAi screen, knockdown of the Caeel
flp-2 gene resulted in lethality in the embryo or larval stages or
resulted in postembryonic growth defects (Simmer et al.,2003). No
visible phenotypes have been identified in a Caeel FLP-2 receptor
knockdown that would affect both splice variants.
Caeel C46F4.1 GPCR was found to be involved in an egg laying-
defective phenotype (egl) in C. elegans. The most related receptor
in D. melanogaster is Drome CG13229; however, no ligand or
function has been ascribed to this unnamed fly receptor. Flyat-
las lists low expression in the D. melanogaster nervous system.
Caeel C46F4.1 is equivalent to egl-6 (Ringstad and Horvitz, 2008)
and two receptor isoforms that differ at the amino-terminus are
produced by alternative splicing and alternate start sites. Caeel
egl-6 is predominately expressed in HSN motor neurons that
innervate vulval muscles and glia-like cells located in the head
region. Weaker expression was also noted in DVA tail interneurons.
Expression was sometimes seen in lateral interneurons SDQL and
SDQR (Ringstad and Horvitz, 2008). A gain-of-function mutant
(n592gf) that results from a single amino acid change, Alanine 135
to Threonine 135, in the third transmembrane domain enhances
EGL-6 activity. The result of this receptor activation is an egg
laying-defective phenotype. Thus, EGL-6 normally transduces sig-
nals that confer inhibitory activity on the HSN motor neurons.
This activity is dependent, in part, on Go signaling. Transgenic
overexpression of Caeel flp and other neuropeptide genes in both
wild type and animals that carried an egl-6 deletion suggested
that the ligands for EGL-6 were dependent on Caeel flp-10 and
Caeel flp-17 genes. This was further supported by the demonstra-
tion that a Caeel flp-10 deletion mutant suppressed the egg laying
defect in the gain-of-function mutant and suppression was further
enhanced by deletion of the Caeel flp-17 gene. Peptides FLP-10 and
two unique peptide sequences FLP-17-1 and 2, proved to be potent
activators of EGL-6 when expressed in X. laevis oocytes. A GIRK
channel assay, used to monitor expression, demonstrated that all
peptides were potent activators, with EC50 values in the nM range
(Table 1). Expression of Caeel flp-17 is confined to anterior BAG
sensory neurons and this expression is necessary for EGL-6 func-
tion in egg laying. Expression of Caeel flp-10 occurs in numerous
neurons ASIL, ASIR, DVB, PVCL, PVCR, PVR as well as in non-
neuronal tissues including head mesodermal cells, vulval tissue,
uterine cells, and spermathecae. Only non-neuronal expression of
Caeel flp-10 appears to be important in EGL-6 action on egg laying
(Ringstad and Horvitz, 2008).
PIGMENT DISPERSING FACTOR AND RECEPTOR
Pigment dispersing hormone is a light adapting hormone origi-
nally identified as responsible for daily rhythms of color change in
Crustacea (Meelkop et al., 2011). Similar peptides known as pig-
ment dispersing factors (PDFs) have been identified in arthropods
and they are required for normal circadian control of locomotion.
In D. melanogaster, the PDF receptor (DromePDFR; CG13758)
null mutant does not show any apparent morphological defects.
Drome PDFR immunostaining revealed that DromePDFR was
localized in 13 neurons in each hemisphere of the adult brain,
4 I-LNV neurons, one of the six LNd neurons, seven neurons
in the DN1 area, and one neuron in the DN3 area. In a 12-h
Light/Dark cycle, the receptor null mutants started morning activ-
ity later than wild type and began evening activity earlier than wild
type. Placing animals in 24 h dark conditions for 8 days resulted
in a loss of rhythmic activity. This behavior is seen in Drosophila
PDF mutants, suggesting that DromePDF and DromePDFR may
be part of a pathway that controls rhythmic circadian behavior.
DromePDFR can be activated with Drome PDF, pituitary adeny-
late cyclase activating polypeptide (PACAP), or calcitonin-like
peptides (Drome DH31; Mertens et al., 2005c).
A search of the C. elegans database for a PDF receptor (PDFR)
ortholog using the Drosophila PDFR (CG13758) as a query
sequence (Renn et al., 1999) resulted in the identification of the
gene Caeel C13B9.4 as coding for a Caeel PDFR. Transcription and
alternate splicing of gene Caeel C13B9.4 mRNA gives rise to six
mRNAs (Wormbase). Two mRNAs that differ by variable length
of the 5′ untranslated region specifies one of three related recep-
tors. These three receptor isoforms differ at the amino-terminal
region of the proteins, generating receptors of 543 aa (Caeel PDFR-
1a); 536 aa (CaeelPDRF-1b), and 541 aa (Caeel PDRF-1c). Caeel
C13B9.4 promoter-driven reporter expression showed that expres-
sion of this receptor is extensive. Expression was observed in
chemosensory neurons PHA and PHB, mechanosensory neurons
PLM,ALM, FLP, OLQD, and OLQV, the ring motor neuron RMED,
the I1 pharyngeal interneuron pair, and a single sensory neuron R3
in the male tail. In non-neuronal tissue, expression was found in 95
body wall muscles and two vulval cells (Janssen et al., 2008b). This
localization is similar to the localization of PDF-like neuropep-
tides which are found in neurons involved in chemosensation,
mechanosensation, oxygen sensing, and locomotion (Janssen et al.,
2008b). Expression of each of the three receptor isoforms in stably
transformed CHO cells demonstrated that only three of 156 syn-
thetic C. elegans peptides were active in a calcium bioluminescence
assay. These included Caeel PDF-1a, PDF-1b, and PDF-2=NLP-
37 (Table 1). These three peptides were most active with Caeel
PDFR-1b but showed reduced activity with Caeel PDFR-1a. Caeel
PDFR-1c was inactive in this assay. In a cAMP activation assay in
transiently transfected HEK293 cells, all three receptor isoforms
were activated by Caeel PDF-1a, Caeel PDF-1b, and Caeel PDF-2,
which suggests signaling through Gαs. In this assay, Caeel-PDFR-
1b was the most active and responded particularly to Caeel PDF-2.
Caeel PDFR-1c was the least active isoform. Cells expressing Caeel
PDFR-1 responded to all three peptides in a dose-dependent man-
ner,using the ability to inhibit forskolin-induced cAMP formation,
which suggests that Caeel PDFR-1c may participate in coupling
with additional G-proteins such as Gαi/o.
A Caeel pdf-1 (lf) results in a decrease in the speed of movement
of worms, an increase in the reversal frequency and an increase
in the frequency of directional change. The net result is that the
distance that animals travel in the forward direction is dramati-
cally reduced. These locomotor defects are not seen in animals in
which Caeel pdf-1 is over-expressed. In contrast, overexpression of
Caeel pdf-2 results in a phenotype equivalent to the Caeel pdf-1(lf).
Overexpression of Caeel pdfr-1 (expressing all 3 isoforms) results
in animals that show a dramatic increase in reversal frequency but
lack changes in speed of movement or directional change. The cur-
rent model is that Caeel PDF-1 peptides activate Caeel PDFR-1 to
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stimulate forward movement and/or inhibit backward movement
and this effect is counter-balanced by Caeel PDF-2 acting on Caeel
PDFR-1 to inhibit forward movement and/or stimulate backward
movement (Janssen et al., 2008b). D. melanogaster clock genes have
counterparts in C. elegans. Null alleles of C. elegans clock genes
reduced mRNA levels of Caeel pdf-1a, pdf-1b, and pdf-2 which
implicates Caeel PDF-1 and 2 activity as dependent on the clock
genes. Caeel pdf-1 appears to work independently of Caeel pdf-2
as the level of one does not affect the other (Janssen et al., 2009).
CHOLECYSTOKININ AND ITS RECEPTOR
Cholecystokinin (CK) is known in vertebrates as a regulator of
food intake as it functions to stimulate smooth muscle contraction
which, in vertebrates, includes intestinal and gall bladder contrac-
tions. CK also stimulates the secretion of digestive enzymes such
as α-amylase (Dufresne et al., 2006). The D. melanogaster CK-like
receptor (Drome CCKLR) was identified based on homology to
mammalian CK receptors (CKR) and was found in mammalian
expression assays to bind to a sulfated FMRFamide-like peptide,
drosulfakinin (Drome DSK). The sulfated form of Drome DSK is
necessary to achieve specific interaction with EC50 values in the
nM range (Kubiak et al., 2002). Analysis of loss-of-function muta-
tions in either Drome CCKLR or Drome DSK results in neuromus-
cular junction undergrowth suggesting that both GPCR and ligand
are required pre-synaptically to promote neuromuscular junction
growth. Genetically, Drome CCKLR and Drome DSK were found
to function upstream of Gαs which in turn regulates a cAMP-
dependent protein kinase which then acts on a transcriptional
regulatory protein CREB2 which is the primary effector of the
pathway (Chen and Ganetzky, 2012). In C. elegans, CaeelY39A3B.5
shares 67% similarity with mammalian CKR (CCK2R) and 64%
with sulfakinin receptors (DK-R1; Johnsen, 1998; Janssen et al.,
2008a). Through computer predicted alternate splicing, Caeel
Y39A3B.5 produces four isoforms of 582 aa (Y39A3B.5a), 552 aa
(Y39A3B.5b), 471 aa (Y39A3B.5c), and 617 aa (Y39A3B.5; Worm-
base). Additional isoforms may exist as two further isoforms were
identified as a result of sequencing DNA generated experimen-
tally by reverse-transcriptase PCR. Both contained the first eight
exons of isoform c but then differed, as one contained the last
two exons of isoform b (Y39A3B.5c/b=Caeel CKR-2a) and the
second the last four exons of isoform d (Y39A3B.5c/d=Caeel
CKR-2b). These two receptors were de-orphaned by transient
expression in CHO cell lines, using a calcium bioluminescence
assay. Caeel NLP-12a and Caeel NLP-12b were the only peptides
tested that activated Caeel CKRs in a dose-dependent manner
(Table 1). The most potent ligand for Caeel CKR-2a was Caeel
NLP-12b whereas NLP-12a showed a higher potency than NLP-
12b with CKR-2b. NLP-12 is localized to a tail interneuron DVA
and to processes from DVA that extend around the nerve ring.
Expression was also observed in all six coelomocytes. In com-
mon with vertebrates, Caeel NLP-12 can regulate digestion since
Caeel ckr-2(lf) have decreased intestinal α-amylase and both Caeel
ckr-2(lf) and Caeel nlp-12(lf) animals gain fat even though there
is no difference in pharyngeal pumping rate or defecation rate.
Caeel ckr-2 and its ligand, Caeel nlp-12, may also be involved in
a mechanosensory feedback loop that couples muscle contraction
to changes in pre-synaptic ACh release (Hu et al., 2011).
ALLATOSTATIN-LIKE PEPTIDES AND RECEPTORS
Mammalian galanin is a neuropeptide that regulates numerous
physiological processes including neurotransmission, nociception,
feeding and metabolism, energy, and osmotic homeostasis as well
as learning and memory (Lang et al., 2007). Insect allatostatins
(ASTs) have a carboxyl-terminal sequence Y (Xaa) FGL-amide and
have multiple functions that include inhibition of juvenile hor-
mone biosynthesis (Bendena et al., 1999; Tobe and Bendena, 2012)
inhibition of muscle contraction, regulation of digestive enzymes,
and neuromodulation (Tobe and Bendena, 2012). In Drosophila
Drome FGL-amide ASTs do not inhibit juvenile hormone biosyn-
thesis. RNAi reduction in Drome AST or Drome ASTR transcripts
results in reduced locomotory behavior in the presence of food.
Locomotion is normal in the absence of food. Reduction in Drome
AST and Drome ASTR is correlated with decreased for tran-
script levels which encodes cGMP-dependent protein kinase. A
reduction in the for transcript is known to be associated with a
naturally occurring allelic variation that creates a sitter pheno-
type in contrast to the rover phenotype which is caused by a for
allele associated with increased for activity (Wang et al., 2012). In
C. elegans the gene Caeel npr-9 expresses a single GPCR isoform
of 444 aa that shares 33 and 37% amino acid sequence identity
with mammalian galanin receptor 2 and the Drome allatostatin
receptor (Drome ASTR), respectively. Promoter-driven reporter
expression suggests that Caeel npr-9 is transcribed exclusively in
interneuron AIB. Caeel NPR-9 appears to function as an inhibitor
of local search behavior in the presence of a food stimulus. In
the absence of food. Caeel npr-9 (lf) mutants display locomo-
tory activity that is identical to wild type animals. Caeel npr-9
(lf) mutants behave as if AIB is stimulated (increased pivoting
and local search). Caeel npr-9(lf) animals also accumulate fat at
an accelerated rate relative to wild type and thus again resem-
ble galanin/allatostatin neuropeptides that affect metabolism. This
contrasts with Caeel npr-9(gf) animals (overexpression of Caeel
NPR-9) which display enhanced forward locomotion that mimic
the phenotype displayed by AIB laser ablation or a mutation in the
glutamate receptor-1 (Bendena et al., 2008). Caeel npr-9(gf) ani-
mals travel long distances off food, presumably as a result of over-
riding dopamine, and glutamate signals that evoke “area restricted
search” behavior in wild type animals. Area restricted search is
characterized by frequent reversals and sharp omega-turns that
function to maximize the time spent on an abundant food source
(Hills et al., 2004). The ligands for Caeel NPR-9 have not yet been
identified. Two genes, Caeel nlp-5 and Caeel nlp-6, specify peptides
that resemble ASTs. Caeel nlp-5 and Caeel nlp-6 specify peptides
with carboxyl-terminal MGLamide and MGFamide, respectively.
Caeel nlp-6 encodes a peptide with carboxy-terminal FGFamide.
A mutation in Caeel nlp-5 has been reported to result in animals
with altered locomotory behavior on food (Bargmann, Worm-
base), which appears to be similar to behaviors exhibited by Caeel
npr-9(lf) animals.
PERSPECTIVES
High throughput neuropeptide projects are expected to facilitate
de-orphanization of all of the predicted D. melanogaster and C.
elegans neuropeptide receptors. These neuropeptides and their
receptors will serve as starting points to understand the functional
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significance of these signaling events. Both organisms serve as
genetic models not only for matching GPCRs with their respec-
tive neuropeptide ligand but offer a means of uncovering signal
transduction pathways that lead to novel behaviors. Genetic mod-
ifier screens and genome-wide RNAi screens will certainly identify
many of the neuropeptide signaling components. C. elegans trans-
genic studies will allow the manipulation of neuropeptide receptor
signaling at the level of a single cell or tissue within an entire
organism. As many of these receptors have counterparts in mam-
mals, it will not be surprising to find similar signaling pathways
conserved throughout evolution.
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